UroSure Wholesale
For Healthcare Professional Use Only.
Solutions / OB/GYN and Women's Health

One urine specimen replaces three workups.

Vaginitis, BV, yeast, and STI all from a single point-of-care urine cup. Designed for the visit cadence of OB/GYN and women's-health practices — including prenatal screening windows.

Request wholesale pricing Order a sample kit
UroSure point-of-care urine test kit
FIG. 01 — UroSure kit
The problem

One complaint, three labs, three turnaround times.

Symptomatic vaginitis is one of the highest-volume presentations in OB/GYN, and the standard workup fragments across vaginal swab, wet mount, urine, and send-out NAAT. Every fragment is a delay. In pregnancy, those delays cost screening windows.

  • 01 Vaginitis, BV, yeast, and STI workups currently require multiple specimen types routed to multiple labs — sometimes a different specimen for each analyte.
  • 02 Patients return for follow-up visits while waiting for results, doubling chair time per encounter.
  • 03 Prenatal STI screening windows are time-sensitive and a send-out delay can move a positive result outside the actionable interval.
  • 04 Wet-mount workflow assumes microscopy proficiency that not every site staffs consistently.
UroSure fit

Six analytes, one specimen, one visit.

UroSure consolidates the most common vaginitis/STI panel into a single urine specimen and a fifteen-minute readout. The kit fits the well-woman intake cadence and the prenatal-screening cadence equally — no microscopy, no separate swab handoff, no send-out delay.

01

Fit

  • One urine specimen replaces vaginal swab, BV-yeast panel, and STI NAAT for the analytes UroSure detects.
  • Result returns within the same visit, so positive findings are documented before the patient leaves.
  • Supports prenatal screening protocols where the window is short and same-visit data matters.
  • Routine retest workflows fit the same cassette without retraining staff or changing the specimen type.
02

Use cases

  • Symptomatic vaginitis workup (discharge, itching, irritation).
  • Routine prenatal STI screening at the recommended visit cadence.
  • Annual well-woman visit with opt-in sexual-health panel.
  • Routine retest follow-up where a single-specimen workflow lowers patient burden.
03

Economics

  • Replaces three to four send-out lab line items with a single in-office procedure.
  • Adds point-of-care billing revenue without rebuilding your encounter workflow.
  • Reduces the second-visit no-show rate that erodes follow-up screening completion.
  • Single-SKU inventory removes the multi-vendor swab/transport-media line items.
Common questions

OB/GYN and Women's Health, in detail.

01 Is UroSure validated for prenatal screening?
TBD — the client provides validation data for prenatal screening windows. Confirm before adopting for prenatal use.
02 Does the urine specimen replace pelvic exam findings?
No. UroSure detects analytes from urine. Pelvic examination, wet-mount, and clinician-collected swabs remain clinical decisions and may still be indicated.
03 Can UroSure be used for routine retest workflows?
TBD — the client confirms the recommended retest interval for each analyte. UroSure does not replace test-of-cure protocols where a different specimen type or method is clinically indicated.
04 Does UroSure detect HSV or HPV?
No. The panel covers Chlamydia, Gonorrhea, Trichomonas, Mycoplasma genitalium, Candida, and Gardnerella. HSV/HPV are out of scope and require separate workflows.
05 How does this integrate with our EHR?
Result is read at point of care and documented in the encounter note like any other in-office test. There is no separate cloud data layer — data does not leave the clinic (TBD: client confirms HIPAA posture).
Next step

Bring UroSure to your practice.

Order a paid five-pack sample, or request a wholesale pricing quote sized for your practice.

Order a sample kit Request pricing